PACKING
A pre-filled syringe containing non-pyrogenic Hyaluronic acid 20mg (1200/1400 kDa), and a vial of 80mg sterile amino acid solution (glycine, L-proline, L-lysine, L-leucine HCl).
JALUPRO® IS CLINICALLY TESTED
JALUPRO® HMW TREATMENT FREQUENCY
A series of 2/3 treatments at 1/2 week intervals, 2 times a year.
APPLICATION
It can be injected into the reticular (lower) or papillary (superior) dermis with any technique (linear, multi-puncture, grid, fan-like). It is recommended to use a 27G needle. The use of a cannula is also possible.
INSTRUCTION FOR USE: We attach a 27G needle to the syringe and inject the Hyaluronic acid into the vial of amino acids, then shake the vial until we have a relatively viscous solution. The amount of product injected into the application points depends on various factors such as the depth of the wrinkles, how intense the signs of expression are, etc., the doctor’s judgment is about the amount of the product depends on the case.
ICE MARKED III – MEDICAL DEVICE
;